, Aux médecins du service de Pneumologie qui m'ont accueilli pendant mon inter CHU à Paris: Pr Marie Wislez pour votre gentillesse et pour m'avoir également permis de réaliser cette thèse
,
Délais de prise en charge des CP II.III.3.A Disponibilité des dates Au total, les dates de onze événements ou actes ont été recueillies lors de cette étude ,
, Cancer du Poumon. Institut National de Veille Sanitaire
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies, BMJ, vol.321, pp.323-332, 2000. ,
, Service des maladies chroniques et dispositifs d'accompagnement des malades-INCa/Département Diffusion des bonnes pratiques et information des malades, Cancers broncho-pulmonaires. Les Parcours de Soins/ Juillet, 2013.
The IASLC Lung Cancer Staging Projet: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eight) Edition of the TNM Classification for Lung Cancer, J Thorac Oncol, vol.11, issue.1, pp.39-51, 2015. ,
BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts), ASCO Meet Abstr, vol.31, p.8000, 2013. ,
Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer, N Engl J Med, vol.373, issue.2, pp.123-158, 2015. ,
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer, N Engl J Med, vol.373, issue.17, pp.1627-1666, 2015. ,
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-small-cell lung cancer, N Engl J Med, vol.375, pp.1823-1833, 2016. ,
Effect of delays on prognosis in patients with non-small cell lung cancer, Thorax, vol.59, pp.45-49, 2004. ,
,
, Timeliness of care and prognosis in patients with lung cancer, Ir J Med Sci, vol.183, pp.383-90, 1971.
Treatment delays in non-small cell lung cancer and their prognostic implications, J Thorac Oncol, vol.6, issue.7, pp.1254-1263, 2011. ,
Survival after community diagnosis of early-stage non-small cell lung cancer, Am J Med, vol.127, issue.5, pp.443-452, 2014. ,
Outcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor, Lung Cancer, vol.40, pp.67-72, 2003. ,
The NHS Cancer Plan : The Cancer Reform Strategy, 2007. ,
, Clinical and Organizational Factors in the Initial Evaluation of Patients With Lung Cancer: Diagnosis and Management of Lung Cancer
, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, vol.143, pp.121-141, 2013.
Quality of care for oncologic conditions and HIV : a review of the literature and quality indicators. RAND Corporation, 2000. ,
Target wait times for cancer surgery in Ontario. Final report-revised, 2006. ,
, Dutch Association of Physicians for Pulmonary Disease and Tuberculosis. Non-small cell lung cancer guideline: staging and treatment. Van Zuiden Communications, 2004.
, Délais de prise en charge des quatre cancers les plus fréquents dans plusieurs régions de
sein, poumon, côlon et prostate, 2011. ,
The effect of a Lung Cancer Care Coordination Program on Timeless of Care, Clinical Lung Cancer, vol.14, issue.5, pp.527-534 ,
Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study, Cancer Epidemiol, vol.39, pp.1136-1180, 2015. ,
Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival, Radiother Oncol, vol.115, pp.257-63, 2015. ,
Lung cancer: clinical presentation and specialist referral time, Eur Respir J, vol.24, pp.898-904, 2004. ,
,
, Rev Mal Respir, vol.31, pp.208-221, 2014.
Implications of a negative bronchoscopy on waiting times to treatment for lung cancer patients: results of a prospective tracking study, J Cardiothorac Surg, vol.34, pp.479-483, 2008. ,
Epidemiologie et délais de prise en charge de 355 patients avec cancer du poumon, Rev Mal Respi, vol.23, pp.43-51, 2006. ,
, Plan cancer, Priorités et objectifs. INCa Février, 2014.
, Projet Stratégique. AP-HP, pp.2015-2019
, Projet de gestion des risques et qualité. AP-HP, pp.2015-2019
Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning, Lung Cancer, vol.75, pp.336-377, 2012. ,
Time to treat : a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis, J Thorac Oncol, vol.2, issue.11, pp.1001-1007, 2007. ,
Are we achieving the current waiting time targets in lung cancer treatment? Result of a prospective study from a large United Kingdom teaching hospital, J Cardiothorac Surg, vol.2, p.5, 2007. ,
Delays in the diagnosis and treatment of lung cancer, CHEST J, vol.128, pp.2282-2288, 2005. ,
Multidisciplinary management of lung cancer: how to test its efficacy?, J Thorac Oncol, vol.2, issue.1, pp.69-72, 2007. ,
the quality of cancer patient experience: perspectives of patients, family members, providers and experts, Qual Saf Health Care, vol.19, pp.584-489, 2010. ,
Nurse Navigators in Early Cancer Care : a randomized controlled trial, J Clin Oncol, vol.32, pp.12-18, 2014. ,
What does satisfaction with wait times mean to cancer patients ?, BMC Cancer, vol.15, pp.10-17, 2015. ,
, Evolution de l'activité d'HDJ de Pneumologie en nombre de patients et de séjours Avant parcours, Mai 2015 à Avril 2016 Après parcours: Mai, vol.2, 2016.
, * source: PMSI